Cited in:


This article has been cited by:

  1. 1
    Liam A. McDonnell, Andreas Römpp, Benjamin Balluff, Ron M. A. Heeren, Juan Pablo Albar, Per E. Andrén, Garry L. Corthals, Axel Walch, Markus Stoeckli, Discussion point: reporting guidelines for mass spectrometry imaging, Analytical and Bioanalytical Chemistry, 2014,


  2. 2
    Bogdan Munteanu, Björn Meyer, Carolina von Reitzenstein, Elke Burgermeister, Susanne Bog, Andreas Pahl, Matthias P. Ebert, Carsten Hopf, Label-Freein SituMonitoring of Histone Deacetylase Drug Target Engagement by Matrix-Assisted Laser Desorption Ionization-Mass Spectrometry Biotyping and Imaging, Analytical Chemistry, 2014, 86, 10, 4642


  3. 3
    Samira Laouirem, Julie Le Faouder, Theodore Alexandrov, Denis Mestivier, Thibaut Léger, Xavier Baudin, Mouniya Mebarki, Valérie Paradis, Jean-Michel Camadro, Pierre Bedossa, Progression from cirrhosis to cancer is associated with early ubiquitin post-translational modifications: identification of new biomarkers of cirrhosis at risk of malignancy, The Journal of Pathology, 2014, 234, 4
  4. 4
    Julie Le Faouder, Samira Laouirem, Theodore Alexandrov, Soundes Ben-Harzallah, Thibaut Léger, Miguel Albuquerque, Pierre Bedossa, Valérie Paradis, Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry, PROTEOMICS, 2014, 14, 7-8
  5. 5
    T. Bittermann, M. A. Hoteit, P. L. Abt, K. A. Forde, D. Goldberg, Waiting Time and Explant Pathology in Transplant Recipients With Hepatocellular Carcinoma: A Novel Study Using National Data, American Journal of Transplantation, 2014, 14, 7